Fundraising FoxEQT — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
1X is an AI and robotics company developing general-purpose humanoid robots for home and industrial use.
AI & Machine LearningConsumerHardwareRoboticsPalo Alto, US
Bernt Øyvind Børnich(CEO, Founder)inBernt Børnich(Founder)in
Co-investorsAccess Ventures (New York)AF WPartnersAlliance VCAlliance VentureavraEQT Ventures+14 more
Adevinta operates a portfolio of online classifieds and digital marketplaces spanning consumer goods, mobility, real estate, holiday rentals, and jobs.
ConsumerE-commerceMarketplaces
Antoine Jouteau(CEO)in
Co-investorsGeneral AtlanticTCV13books CapitalAnkaa VenturesCollective SparkFJ Labs+5 more
Bluebook provides AI agents that handle research, reconciliations, and month-end closing work for accounting firms, enabling each professional to manage a significantly larger client base and freeing time for strategic advisory work.
AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US
Philip Andersson(CEO)inFilip Stål(CTO)inJonathan Andersson(Founder)
Co-investorsY CombinatorEQT Ventures
Harvey provides domain-specific AI products for legal and professional services firms, enabling contract analysis, due diligence, compliance, and litigation tasks.
AI & Machine LearningEnterprise SoftwareLegalTechSan Francisco, US
Winston Weinberg(Founder)inGabe Pereyra(Founder)inGabriel Pereyra(Founder)inWinston Weinberg Gabriel Pereyra(Founder)
Co-investorsAndreessen HorowitzKleiner PerkinsOpenAI Startup FundArtisanal VenturesCaesar VenturesCoatue Management+29 more
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.
BiotechHealthtechMedical Devices
Ilise Lombardo(Chief Executive Officer)inVolker Knappertz(Executive Vice President of Research & Development)inMichael Samar(Chief Financial Officer)inRob Lasser(Chief Medical Officer)in
Co-investorsBioMedPartnersJeito CapitalRoche Venture FundSofinnova PartnersEQT Life SciencesForbion+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.